Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Patients Treated With Natalizumab
Conditions
Interventions
natalizumab
Locations
7
Switzerland
Research Site
Aarau, Switzerland
Research Site
Basel, Switzerland
Research Site
Bern, Switzerland
Research site - private practice
Lucerne, Switzerland
Research Site
Lugano, Switzerland
Research Site
Wohlen, Switzerland
Start Date
March 20, 2015
Primary Completion Date
January 28, 2018
Completion Date
January 28, 2018
Last Updated
September 13, 2018
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions